CompletedNot Applicable

The Oncopanel Pilot (TOP) Study

Canada432 participantsStarted 2014-10

Plain-language summary

The BCCA Oncopanel is a clinical assay being developed to determine genotype status of a prospectively defined set of genes. The purpose of this pilot study is to assess the feasibility and effect on clinical-decision-making of the Oncopanel test. Eligible patients are those with advanced lung, colorectal, melanoma and GIST cancers and patients with diagnosed malignancies being considered for clinical trials.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Patients with archival tumor tissue and a known history of invasive malignancies are eligible if they meet one or more of the following criteria: * Advanced colorectal cancer and eligible for standard KRAS testing, * Advanced non-small cell lung cancer and eligible for standard EGFR testing, * Advanced melanoma and eligible for standard BRAF testing, * Gastrointestinal stromal tumors (GISTs) eligible for standard c-KIT and PDGFRA testing, * Being considered for potential eligibility in clinical trial.

What they're measuring

Number of days between receipt of archival tumour tissue and generation of the OncoPanel Report

Timeframe: 10 business days

Trial details

NCT IDNCT02171286

SponsorBritish Columbia Cancer Agency

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-03

View on ClinicalTrials.gov More Colorectal Cancer Metastatic trials